Arcus Biosciences
RCUS
RCUS
190 hedge funds and large institutions have $1.37B invested in Arcus Biosciences in 2025 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 61 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 185 → 190 (+5)
7% more repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 61
0.36% more ownership
Funds ownership: 94.18% → 94.53% (+0.36%)
Holders
190
Holding in Top 10
2
Calls
$46.2M
Puts
$2.19M
Top Buyers
| 1 | +$13.5M | |
| 2 | +$8.97M | |
| 3 | +$6.66M | |
| 4 |
DC
Decheng Capital
Menlo Park,
California
|
+$4.03M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$3.93M |
Top Sellers
| 1 | -$17M | |
| 2 | -$3.29M | |
| 3 | -$2.88M | |
| 4 |
Jane Street
New York
|
-$2.67M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.45M |